Funding for AUPN's symposium on "Combining Clinical and Research Careers in Neuro

描述（由申请人提供）：本申请寻求资助一个为期一天半的指导研讨会，题为“如何联合收割机临床和研究职业神经科学（CCRCN）"。该计划由大学神经病学教授协会（AUPN）（www.aupn.org），以及国家神经疾病和中风研究所（NINDS），美国神经学协会（ANA）和儿童神经学会（CNS）赞助。AUPN是美国经认证的医学院神经病学系主任或部门的专业组织。它的目标是“通过向神经病学受训者提供上级教育和扩展有关神经疾病的知识，在神经疾病患者的护理方面取得卓越成就。“另外两个专业组织，美国神经学协会（ANA）和儿童神经学学会（CNS），分享AUPN和NINDS对临床科学家数量下降的担忧，并加入了AUPN和NINDS，为CCRCN提供财政支持。 CCRCN研讨会于2003年首次由AUPN和NINDS提供，以满足对更多临床科学家的迫切需求，特别是在神经病学方面。2005年，《美国医学会杂志》报告说，只有不到2%的医生是科学家，尽管研究活动和资金有所增加，但这一数字仍在继续下降。当这个项目在2003年开始时，趋势显示了二十年来不断增加的生物医学研究资金，但临床科学家劳动力却惊人地减少了22%;研究表明，超过三分之一的医学院校毕业生没有实现他们成为活跃的临床科学家的最初目标。 本次研讨会的具体目的是：1）鼓励接受神经科学研究训练的医学生进行临床训练（特别强调神经病学）; 2）描述和讨论成功融合临床和研究职业的策略; 3）讨论研究和临床职业相结合的满意度和力量; 4）描述和讨论的来源，和战略，获得长期的培训和研究支持;和5）为学生提供一个机会，以满足和网络与院士谁已经成功地结合在神经科学的临床和研究事业。 邀请可能是神经科学研究和临床职业的候选人的医学生申请参加这次会议。理想的候选人将完成临床前培训和至少一年的神经科学研究培训。进一步考虑谁已经完成了一些必要的临床实习的学生，因为这是很多学生将考虑进一步的临床培训的时候。 本次研讨会与使命高度相关 NINDS，这是为了减轻神经系统疾病的负担。这一值得称赞的目标得到了CCRCN的直接支持，CCRCN致力于增加训练有素的临床科学家的数量，以寻找治疗方法，甚至治愈神经系统疾病。

DESCRIPTION (provided by applicant): This application seeks funding for a one and a half day mentoring symposium entitled "How to Combine Clinical and Research Careers in Neuroscience (CCRCN)". The program is sponsored by the Association of University Professors of Neurology (AUPN) (www.aupn.org), together with the National Institute of Neurological Disorders and Stroke (NINDS), the American Neurological Association (ANA) and the Child Neurology Society (CNS). The AUPN is the professional organization for Chairs of Neurology Departments, or Divisions, in accredited medical schools in the United States. Its goal is "excellence in the care of patients with neurological disease by providing superior education to neurology trainees and by expanding knowledge about neurologic diseases." Two other professional organizations, the American Neurological Association (ANA) and The Child Neurology Society (CNS), share AUPN's and NINDS' concerns regarding the decline in the number of clinician-scientists, and have joined AUPN and NINDS financially supporting the CCRCN. The CCRCN symposium was first offered in 2003 by the AUPN and NINDS to meet the urgent need for more clinician-scientists, specifically in neurology. In 2005, JAMA reported that less than 2% of all physicians are scientists and, despite increases in research activity and funding, this number continues to drop. When this program began in 2003, the trend showed two decades of increasing biomedical research funding but an alarming 22% decrease in the clinician-scientist workforce; studies showed that more than a third of medical school graduates with MD/PhD do not realize their original goal of becoming active clinician-scientists. The specific aims for this symposium are to: 1) encourage medical students with neuroscience research training to pursue clinical training (with special emphasis on neurology); 2) describe and discuss strategies for successfully melding clinical and research careers; 3) discuss the satisfactions and power of a combined research and clinical career; 4) describe and discuss sources of, and strategies for, obtaining long term training and research support; and 5) provide an opportunity for students to meet and network with academicians who have successfully combined clinical and research careers in neuroscience. Medical students who may be candidates for combined research and clinical careers in the neurosciences are invited to apply to attend this meeting. The ideal candidate will have completed preclinical training and at least one additional year of neuroscience research training. Further consideration is given to students who have completed some required clinical clerkships, as this is the time when many students will be thinking about further clinical training. This symposium is highly relevant to the mission of NINDS, which is to reduce the burden of neurological disease. This laudable goal is directly supported by the CCRCN which strives to increase the number of well-trained clinician-scientists working to find treatments, and even cures, for neurological diseases.